Amcor Holdings Ltd. delivered stronger-than-expected integration progress at the Jefferies Global Industrials Conference on Sept. 10, telling investors it captured $285 million in year-one synergies — 9.6% above its $260 million target — while reaffirming its three-year merge synergy goal of $650 million.
Chief Executive Steve Scherger said the company also expects to generate roughly $130 million in synergies during an upcoming six-month transition window as it shifts its fiscal year-end to Dec. 31. Integration spend has reached $160 million against a $280 million budget, or 57% of plan, and SG&A reductions have already surpassed $100 million.
Revenue-side synergies are tracking toward a $280 million three-year objective, with about $60 million in EBITDA contribution anticipated. New business wins totaled $140 million, Scherger said.
On pricing, Amcor passed through $280 million of inflation in the quarter just ended, bringing its lag in cost passthrough down to roughly one month from a historical three months during periods of significant disruption. The company acquires more than $13 billion of raw materials annually, about $5 billion of which is resin-based; approximately 4% of that resin procurement comes from the Middle East.
Free-cash-flow guidance was adjusted downward. Amcor now expects about $1.3 billion for 2026, down from an initial range of $1.8 billion to $1.9 billion that was later reduced to about $1.5 billion. Scherger attributed the drag primarily to a $500 million build in working capital, driven largely by accounts receivable and inventory.
Leverage stood at about 3.5 times on total debt of $15.1 billion, with a market capitalization of $19.8 billion and EBITDA of $3.5 billion. The company targets a debt-to-equity ratio of 3.0 times by the end of 2027 and expects to reduce debt by roughly $1 billion over the next 18 months.
Scherger projected 2027 organic revenue growth in the low single digits, mid-single-digit EBITDA expansion fueled by synergy capture, and double-digit EPS growth. Capital expenditure is being raised to 5% of sales from a historical 3% to 4%, with maintenance CapEx at 2% to 3% of sales.
Portfolio simplification is underway. Amcor identified $2.5 billion in top-line sales as non-core, has completed five divestiture transactions totaling $500 million, and faces a remaining sale of its North American beverage bottle business, which produces containers for Gatorade and Powerade brands.
The company's healthcare platform is valued at $2.5 billion. Its core portfolio totals $20 billion, with growth categories accounting for slightly more than half and center-of-store brands making up about 45%.
Volume dynamics improved sequentially. Third-quarter volumes fell 1.5%, but fourth-quarter volumes came in positive 0.5%, reflecting a roughly 200 basis point improvement.
Amcor shares traded near $42.32, down 1.58%, with a price-to-earnings ratio of 18 and a PEG ratio of 0.37. The company pays a dividend yielding about 6% and has raised its payout for seven consecutive years.
